The U.S. Food and Drug Administration has instructed manufacturers of GLP‑1 weight‑loss medications to update their labeling to include a warning about a potential increased risk of a rare eye condition that could lead…
A 14‑month investigation examined why it is difficult to determine where prescription generic drugs are manufactured, how the U.S. Food and Drug Administration monitors drug producers, and what occurs when inspectors…
The U.S. Food and Drug Administration announced that it intends to place the external mechanical stimulator used to alleviate nasal congestion into Class II, subject to specific special controls. The agency cited the…
The U.S. Food and Drug Administration has released a proposal to revise regulations governing nutrient specifications and labeling for infant formula. The draft changes would adjust the minimum and/or maximum levels of…
The U.S. Food and Drug Administration issued a correction to a June 3, 2026 Federal Register notice, clarifying that approval for 16 abbreviated new drug applications (ANDAs) was withdrawn effective July 6, 2026. The…
According to the provided article, the U.S. Food and Drug Administration announced that it is reclassifying the hematopoietic cell enrichment kit as a Class II medical device, applying a set of special controls. The…
The U.S. Food and Drug Administration announced that a system designed to detect nucleic acid from non‑viral microorganisms that cause sexually transmitted infections, when used with home‑collected specimens, will be…
The American Academy of Pediatrics has issued a renewed policy statement urging a federal prohibition on the sale and distribution of unpasteurized milk and other raw dairy products, citing concerns about serious health…
The U.S. Food and Drug Administration issued a correction to a September 13, 2023 Federal Register notice (88 FR 62799) that had announced the withdrawal of Oxandrin (oxandrolone) tablets, 2.5 mg and 10 mg, from sale…
The U.S. Food and Drug Administration is moving to place a high‑throughput DNA sequencing system used to assess hereditary cancer predisposition into Class II, meaning it will be subject to special controls. The agency…
The Clear Labels Act, a bill intended to increase consumer awareness of drug manufacturing origins, is scheduled for a full Senate vote. According to the article, the legislation has been altered, with two critical…